MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why QCLS Stock dropped -3.44% Today — RQD Quant Desk Flash
$0.44 -3.44% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.44
Q/C Technologies Inc. (QCLS) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • SELL / AVOID
Cap $3.6M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.44 (-0.81%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-6.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for QCLS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (42/100 Composite)
🔍 WHY QCLS SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (29% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (24% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$0.63-14.3% Next Q
50
Q2 (-2Q)Grade D$0.54-13% Next Q
47
Q3 (-1Q)Grade D$0.47-6.4% Next Q
45
CurrentGrade D-$0.44-7% Hist 90D α
42
Trajectory: C- (50) → D- (42)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a QCLS Turnaround Squeeze
While QCLS currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.09) and Max Pain ($0.46) forces dealer call-delta covering toward $8.58.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $QCLS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “QCLS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why QCLS Stock dropped -3.44% Today — RQD Quant Desk Flash
Q/C Technologies Inc. (QCLS) dropped -3.44% to $0.44, trading at 2% of its 52-week range ($0.42 – $8.17). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($0.42 – $8.17) with RSI-14 at 27.9 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.44 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 52% gross margin and $0 annual free cash flow.
Live QCLS Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring QCLS)
- ✓Walkthrough of QCLS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
QCLS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -88.27%▼ DESCENDING CHANNEL
2026-10-30O $0.44H $0.46L $0.42C $0.44VOL 317.7K
RES: $0.91SUP: $-1.48SMA50: $1.09SMA200: $3.07
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
QCLS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on QCLS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for QCLS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for QCLS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (QCLS)
Health Care Rank #600 of 1016
⚔️ CDIO vs QCLS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (QCLS vs. CDIO, TRIB, VRAX, BMRA)
Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances (18 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Q/C Technologies Inc. (QCLS) ranks #600 by composite RQD confidence (42/100, grade D-) and #968 by equity capitalization ($3.6M). Within this direct 5-issuer industry benchmark cohort, QCLS leads on earnings valuation at N/A trailing P/E, while QCLS leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. VRAX currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with QCLS at 42/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| QCLS
ACTIVE
Q/C Technologies Inc. | D- | 42/100 | — | — | -35.0% | -3.44% | $3.6M | Benchmark Subject |
| CDIO Cardio Diagnostics Holdings Inc. | E | 31/100 | — | — | -35.0% | +2.94% | $5.2M | /cdio-vs-qcls → |
| TRIB Trinity Biotech plc | D+ | 56/100 | — | — | — | -2.50% | $5.4M | /trib-vs-qcls → |
| VRAX Virax Biolabs Group Limited | D+ | 58/100 | — | — | — | +10.00% | $1.8M | /vrax-vs-qcls → |
| BMRA Biomerica Inc. | D- | 39/100 | — | 8.1% | -35.0% | -0.57% | $8.0M | /bmra-vs-qcls → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001321834In its most recent audited fiscal period (FY2025, filed 2025-12-31), Q/C Technologies Inc. (QCLS) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$11.6M, operating cash flow of -$9.1M, and free cash flow of -$9.1M (-1.0% YoY). On the balance sheet, QCLS closed FY2025 with $41.2M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | -$11.6M | -$9.1M | -$9.1M | $41.2M | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$23.4M | -$9.0M | -$9.0M | $21.4M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$4.0M | -$13.0M | -$13.0M | — | — |
3. QCLS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs QCLS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Q/C Technologies Inc. (NASDAQ: QCLS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.44 (-3.44% 1D, market cap $3.6M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, QCLS ranks #600 in composite RQD confidence.
How does QCLS compare to CDIO and TRIB in the Health Care sector?
Within the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances), QCLS carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CDIO (Cardio Diagnostics Holdings Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $5.2M) and TRIB (Trinity Biotech plc) posts a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $5.4M). Among the 5-stock peer group, QCLS leads on earnings multiple (N/A) while QCLS leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for QCLS?
Per QCLS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001321834), Q/C Technologies Inc. generated $0 in revenue, -$11.6M in net income, and -$9.1M in free cash flow against $41.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is QCLS trading relative to its 50-day, 200-day, and 52-week technical levels?
QCLS last traded at $0.44 (-3.44% on volume of 113,491 shares), positioning the stock -59.63% below its 50-day simple moving average ($1.09) and -85.67% below its 200-day simple moving average ($3.07). Across its 52-week range of $0.42 to $8.17, QCLS sits at the 0.3% percentile with a 14-day RSI of 27.9 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.50).
QCLS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is QCLS stock moving today?
Why QCLS Stock dropped -3.44% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.